Life Sciences 14. October 2021 iThera receives EIC Accelerator Grant The EIC Accelerator Program is Europe’s largest and most selective public funding program for breakthrough innovation projects.
Life Sciences 29. July 2021 Investment in mk2 Biotechnologies OCCIDENT invests in industrial biotech for the first time and participates as lead investor in Munich-based startup mk2 Biotechnologies.